File Download
  Patent History
  • Application
    US 12/255092 2008-10-21
  • Publication
    US 2009325160 2009-12-31
Supplementary

published patent: COMPOSITIONS AND METHODS FOR PROGNOSIS AND THERAPY OF LIVER CANCER

TitleCOMPOSITIONS AND METHODS FOR PROGNOSIS AND THERAPY OF LIVER CANCER
Priority Date2008-10-21 US 12/255092
2004-08-12 US 10/917195
2003-08-13 US 10/494981P
2003-09-04 US 10/500844P
Inventors
Issue Date2009
Citation
US Published patent application US 2009325160. Washington, DC: US Patent and Trademark Office (USPTO), 2009 How to Cite?
AbstractThis invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865) (SEQ ID NO:7), NDRGI (AA486403) (SEQ ID NO:8), EST1 (H50345) (SEQ ID NO:9), TRPC1 (AA017132) (SEQ ID NO:10), GFRA1 (AA512935) (SEQ ID NO:11), EST2 (AA454543) (SEQ ID NO:12), CLDN10 (R54559) (SEQ ID NO:13), DNALI1 (R93087) (SEQ ID NO:14), RBP5 (AA453198) (SEQ ID NO:15), EST3 (AA621761) (SEQ ID NO:16), EST4 (N63706) (SEQ ID NO:17), PCOLCE (AA670200) (SEQ ID NO:18), TDO2 (T72398) (SEQ ID NO:19), EST5 (T47454) (SEQ ID NO:20), HIST1H2BD (N33927) (SEQ ID NO:21), PXMP2 (N70714) (SEQ ID NO:22), ACAS2 (AA455146) (SEQ ID NO:23), ANAPC7 (T68445) (SEQ ID NO:24), EST6 (AA576580) (SEQ ID NO:25), RBP5 (N92148) (SEQ ID NO:26), ANXAI (H63077) (SEQ ID NO:27), CKB (AA894557) (SEQ ID NO:28), ITGBL1 (N52533) (SEQ ID NO:29), KPNA2 (AA676460) (SEQ ID NO:30), EST7 (W90740) (SEQ ID NO:; 31) and MEG3 (W85841) (SEQ ID NO:32). This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy.
Persistent Identifierhttp://hdl.handle.net/10722/176986

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:54Z-
dc.date.available2012-11-30T08:38:54Z-
dc.date.issued2009-
dc.identifier.citationUS Published patent application US 2009325160. Washington, DC: US Patent and Trademark Office (USPTO), 2009en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176986-
dc.description.abstractThis invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865) (SEQ ID NO:7), NDRGI (AA486403) (SEQ ID NO:8), EST1 (H50345) (SEQ ID NO:9), TRPC1 (AA017132) (SEQ ID NO:10), GFRA1 (AA512935) (SEQ ID NO:11), EST2 (AA454543) (SEQ ID NO:12), CLDN10 (R54559) (SEQ ID NO:13), DNALI1 (R93087) (SEQ ID NO:14), RBP5 (AA453198) (SEQ ID NO:15), EST3 (AA621761) (SEQ ID NO:16), EST4 (N63706) (SEQ ID NO:17), PCOLCE (AA670200) (SEQ ID NO:18), TDO2 (T72398) (SEQ ID NO:19), EST5 (T47454) (SEQ ID NO:20), HIST1H2BD (N33927) (SEQ ID NO:21), PXMP2 (N70714) (SEQ ID NO:22), ACAS2 (AA455146) (SEQ ID NO:23), ANAPC7 (T68445) (SEQ ID NO:24), EST6 (AA576580) (SEQ ID NO:25), RBP5 (N92148) (SEQ ID NO:26), ANXAI (H63077) (SEQ ID NO:27), CKB (AA894557) (SEQ ID NO:28), ITGBL1 (N52533) (SEQ ID NO:29), KPNA2 (AA676460) (SEQ ID NO:30), EST7 (W90740) (SEQ ID NO:; 31) and MEG3 (W85841) (SEQ ID NO:32). This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleCOMPOSITIONS AND METHODS FOR PROGNOSIS AND THERAPY OF LIVER CANCERen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.identifier.hkuros92356-
dc.identifier.hkuros164791-
dc.contributor.inventorCheung, STen_HK
dc.contributor.inventorFan, STen_HK
patents.identifier.applicationUS 12/255092en_HK
patents.description.assigneeVERSITECH LIMITEDen_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2009-12-31en_HK
patents.identifier.hkutechidSurg-2003-00126-
patents.date.application2008-10-21en_HK
patents.date.priority2008-10-21 US 12/255092en_HK
patents.date.priority2004-08-12 US 10/917195en_HK
patents.date.priority2003-08-13 US 10/494981Pen_HK
patents.date.priority2003-09-04 US 10/500844Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 2009325160en_HK
patents.relation.familyCN 1867671 (A) 2006-11-22en_HK
patents.relation.familyCN 100549172 (C) 2009-10-14en_HK
patents.relation.familyHK 1098783 (A1) 2010-07-02en_HK
patents.relation.familyUS 2009325160 (A1) 2009-12-31en_HK
patents.relation.familyUS 8076077 (B2) 2011-12-13en_HK
patents.relation.familyUS 2005089895 (A1) 2005-04-28en_HK
patents.relation.familyWO 2005017150 (A1) 2005-02-24en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats